Capital Impact Advisors »

Blueprint Medicines shares owned by Capital Impact Advisors

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Capital Impact Advisors from 13F filings

Historical chart of Capital Impact Advisors investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Capital Impact Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Capital Impact Advisors

Quarter filed Position value Share count Share price at filing
2023-06-30 $675k 11k 63.20
2023-03-31 $456k 10k 44.99
2022-12-31 $321k 7.3k 43.81
2022-09-30 $312k 7.3k 42.59
2022-06-30 $303k 6.0k 50.46
2022-03-31 $537k 8.4k 63.85
2021-12-31 $821k 7.7k 107.08